We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.48%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.63B
AUM Growth
-$655M
(-15%)
Cap. Flow
-$792M
Cap. Flow
% of AUM
-21.84%
Top 10 Holdings %
Top 10 Hldgs %
31.08%
Holding
113
New
24
Increased
24
Reduced
34
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$90.1M |
| 2 |
AerCap
AER
|
+$80M |
| 3 |
Pfizer
PFE
|
+$73.2M |
| 4 |
Illumina
ILMN
|
+$56.4M |
| 5 |
Equifax
EFX
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$262M |
| 2 |
Vulcan Materials
VMC
|
+$208M |
| 3 |
Bausch Health
BHC
|
+$108M |
| 4 |
AGN
Allergan Inc
AGN
|
+$107M |
| 5 |
AGN
Allergan plc
AGN
|
+$82.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.17% |
| 2 | Industrials | 10.32% |
| 3 | Materials | 6.21% |
| 4 | Technology | 5.36% |
| 5 | Financials | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Warner Bros
WBD
$65.9B
| – | – |
-244,431
| Closed | -$8.42M |
|
102
Wells Fargo
WFC
$261B
| – | – |
-307,670
| Closed | -$16.9M |
|
103
Corpay
CPAY
$25B
| – | – |
-285,124
| Closed | -$42.4M |
|
|
ALXN
104
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-70,987
| Closed | -$13.1M |
|
|
MDCO
105
DELISTED
Medicines Co
MDCO
| – | – |
-946,830
| Closed | -$26.2M |
|
|
ESRX
106
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-278,846
| Closed | -$23.6M |
|
|
RLYP
107
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-682,640
| Closed | -$21M |
|
|
RCPT
108
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-363,010
| Closed | -$44.5M |
|
|
INFA
109
DELISTED
INFORMATICA CORP
INFA
| – | – |
-446,753
| Closed | -$17M |
|
|
HOT
110
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| – | – |
-428,517
| Closed | -$34.7M |
|
|
CELG
111
DELISTED
Celgene Corp
CELG
| – | – |
-482,322
| Closed | -$54M |
|
|
AGN
112
DELISTED
Allergan Inc
AGN
| – | – |
-501,268
| Closed | -$107M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q1 2015 Portfolio in Review
As of Q1 2015, PFM Health Sciences held 113 positions worth $3.63B, down 15% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
PFM Health Sciences withdrew a net $792M in Q1 2015, closing 30 positions and reducing 34 holdings. Its most notable exit was Microsoft, an estimated $262M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 50% a quarter earlier, followed by Industrials and Materials.
Against the trend, PFM Health Sciences opened a new position in Jazz Pharmaceuticals worth $90.7M.
- PFM Health Sciences's largest Q1 2015 buy was Jazz Pharmaceuticals: 525,003 shares worth $90.7M.
- PFM Health Sciences added most to AerCap in Q1 2015, an estimated $80M increase.
- PFM Health Sciences's biggest Q1 2015 reduction was Vulcan Materials, cutting an estimated $208M.
- PFM Health Sciences fully exited Microsoft in Q1 2015, selling an estimated $262M.
- PFM Health Sciences's ten largest holdings make up 31% of its $3.63B portfolio in Q1 2015.
- PFM Health Sciences opened 24 new positions and closed 30 in Q1 2015.
- PFM Health Sciences's portfolio value fell 15% quarter-over-quarter to $3.63B.
Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.